Aim. To assess the contribution of human enteroviruses to the overall structure of acute respiratory viral infections in children in Novosibirsk during the epidemic season 2022–2023. Material and Methods. 1132 samples collected from children aged 0–15 years with symptoms of ARVI were analyzed by real–time PCR for the presence of genetic material of respiratory viruses, including enteroviruses. Results. 65.2 % of the examined children were positive for at least one virus, including enteroviruses. Respiratory syncytial virus was most often found in children during this period, which accounted for 17.2 % of the total number of samples studied. Influenza virus was detected in 14.2 % of the examined children. Enteroviruses were detected in 9.2 % of cases and rhinovirus was detected in 10.8 % of the examined children. Conclusions. Respiratory enteroviruses, along with rhinovirus, occupy a significant place in the etiology of acute respiratory viral infections in children. The study of the epidemiology of enteroviruses is necessary to understand the clinical manifestations and outcomes of enterovirus infection, and to assess the burden of diseases caused by enteroviruses, which is important for optimizing prevention and therapy strategies.
The aim of the study was to assess the level of humoral immunity to SARS-CoV-2 in COVID-19 convalescents. Materials and methods. We used ELISA for antibody quantitation, microneutralization test using three SARS-CoV-2 strains for neutralizing activity measurement, Illumina MiSeq platform for NGS sequencing and NextClade resource for phylogenetic analysis. Results. The mean concentration of antibody in convalescents was 133.42 ± 7.2 BAU/mL and the value depended on neither the gender and age of the patients, nor on the time elapsed since COVID-19 infection. The studied SARS-CoV-2 strains were sequenced and deposited in the international GISAID database. According to genetic analysis: EPI_ISL_19424272 phylogenetically belongs to the B1.1 clade, EPI_ISL_19424271 – to B.1.1.397 clade, EPI_ISL_19424270 – to Delta B.1.617.2.122. There were no significant differences in the neutralizing ability of convalescent sera (those who had been ill 2–3 months before the study) for the first two variants of SARS-CoV-2 and it was significantly reduced for the Delta variant, which appeared in the Novosibirsk region later. Conclusions. The neutralizing activity of convalescent sera was the highest against those variants of the virus that the patient had recovered from, while was reduced or absent against the new variant. The antibody developed to the original variants of the SARS-CoV-2 may not be effective enough against newly emerging strains due to the emergence of mutations in the virus that allow it to evade previously developed humoral immune response.
8 December 2025 in Russian Journal of Infection and Immunity
Introduction. Metapneumovirus frequently causes respiratory tract infections in children worldwide, with clinical manifestations ranging from mild upper respiratory tract disease to severe bronchiolitis and pneumonia. However, not all countries conduct regular metapneumovirus infection monitoring that complicates its infection trend analysis. The aim of the work was to analyze the etiological pattern of acute respiratory diseases by assessing proportion of metapneumovirus infection, as well as comparatively assess clinical characteristics of the main acute respiratory viral infections in children in Novosibirsk. Materials and methods. Between November 2019 and May 2024, from children aged 0–17 years, admitted with symptoms of acute respiratory diseases there were collected and analyzed 6468 samples for metapneumovirus and other respiratory viruses using real-time polymerase chain reaction. Results. Viral etiology of acute respiratory diseases in hospitalized children was confirmed in 63.0% (4077/6468) of cases. The etiological ARVI pattern differed significantly in various epidemic seasons. Thus, in 2019–2020, influenza virus (27.8%) and respiratory syncytial virus (21.1%) dominated in the etiology of acute respiratory viral infections, while metapneumovirus was detected only in as few as 1.6% of children. In contrast, in 2020–2021, we observed a sharp increase in the detection rate of metapneumovirus (28%) paralleled with the absence of influenza virus and RSV. At the same time, in the following season (2021–2022) we did not detect any cases of metapneumovirus infection. In the following two seasons, the detection rate of metapneumovirus was about 5%: in children aged 3–6 years it was significantly higher than in infants and children aged 7–17 years. Clinical signs of metapneumovirus infection included fever, cough, dyspnoea, hypoxia and were similar to the manifestations of respiratory syncytial virus infection. At the same time, fever above 39°C and malaise were significantly more frequent in patients with influenza. Conclusion. Understanding the epidemiology of specific respiratory infections, compared with global trends, can help to develop targeted prevention and control measures.